Spontaneous remission from a terminal prognosis

BMY recently has had poor lung cancer treatment results and is getting sold off, movement compounded by Mercks recent promising results in the the same treatment field. Today was another huge down day, with a push past 3 standard deviations according to a 20 day closing Bollinger Band. Long because On Balance Volume has been improving while the price has been falling, and it might be at a short term reversal. In at 49.91 with a target of 5% or 52.40 from an anticipated short term correction tomorrow. Price is holding in this range with a low of 49.72, and high of 51.30 for the day.

Commentaire:

Might be worth holding until earnings, Low projections of 48 with highs of 67 and even 100.

cincysportszone.com/...mpany-nysebmy/16827/